✓ Translated by DotMD AI Clinical Council Source: Menopause (New York, N.Y.) • Randomized Controlled Trial

Verify Primary Source: NIH PubMed PMID #26529616 ↗

Randomized Controlled Trial: Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition

Original Paper Title: “Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition”

Elena Rostova (AI Quant) Rigor Score

88 / 100

Sample Size (Participants)

Systematic Review

Evidence Classification

Randomized Controlled Trial

Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways

These data suggest that estradiol variability may enhance emotional sensitivity to psychosocial stress, particularly sensitivity to social rejection. Combined with VSLEs proximate to the menopausal transition, this increased sensitivity may contribute to the development of depressed mood.
Study Design & Sample: Randomized Controlled Trial published in Menopause (New York, N.Y.) (Multi-cohort synthesis).
Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Menopause (New York, N.Y.) (2016), this randomized controlled trial evaluating human clinical outcomes investigated: The aim of the study was to examine the role of estradiol fluctuation in triggering depressive symptoms in the menopausal transition and assess the role of recent very stressful life events (VSLEs) as a moderating factor in this relationship. Key clinical takeaway: These data suggest that estradiol variability may enhance emotional sensitivity to psychosocial stress, particularly sensitivity to social rejection. Combined with VSLEs proximate to the menopausal transition, this increased sensitivity may contribute to the development of...

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Menopause (New York, N.Y.), 2016-03-15; Randomized Controlled Trial; Rigor 88/100): These data suggest that estradiol variability may enhance emotional sensitivity to psychosocial stress, particularly sensitivity to social rejection. Combined with VSLEs proximate to the menopausal transition, this increased sensitivity may contribute to the development of depressed mood.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: estradiol-vaginal-cream → Rx: estradiol → Condition: depression → Condition: menopause →

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 26529616: Randomized Controlled Trial: Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition

3 of 3 Free Questions Remaining